Skip to main content
SpringerLink
Log in

Virushepatitis A–E

Viral hepatitis A–E

  • CME Weiterbildung · Zertifizierte Fortbildung
  • Published:
Der Gastroenterologe Aims and scope

Zusammenfassung

Bis heute sind 5 primär hepatotrope Hepatitisviren identifiziert: das Hepatitis-A Virus (HAV), das Hepatitis-B-Virus (HBV), das Hepatitis-C-Virus (HCV), das Hepatitis-D-Virus (HDV) und das Hepatitis-E-Virus (HEV). Weitere Non-A–E-Hepatitisviren (GBV-C, HGV, TTV, SENV u. a.) sind bisher nicht als Ursache einer akuten oder chronischen Lebererkrankung gesichert und spielen in der Praxis keine Rolle. Im Folgenden werden Klinik, Diagnostik, Therapie und Prävention der Hepatitis A–E zusammenfassend dargestellt werden.

Abstract

Five primary hepatotropic viruses have been identified to date: hepatitis A virus (HAV), hepatitis B (HBV), hepatitis C (HCV), hepatitis D (HDV) and hepatitis E (HEV). Other non-A–E hepatitis viruses, e.g. GBV-C, HGV, TTV and SENV have not yet been shown to cause hepatitis in humans and are therefore clinically irrelevant. This review summarizes our current knowledge on the diagnosis, prevention and therapy of hepatitis A–E.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Craxi A, Di Bona D, Camma C (2003) Interferon-alpha for HBeAg-positive chronic hepatitis B. J Hepatol 39: S99–105

    Google Scholar 

  2. Di Marco V, Lo Iacono O, Camma C et al. (1999) The long-term course of chronic hepatitis B. Hepatology 30: 257–264

    Google Scholar 

  3. Emerson SU, Purcell RH (2003) Hepatitis E virus. Rev Med Virol 13: 145–154

    Google Scholar 

  4. Ganem D, Prince AM (2004) Hepatitis B virus infection — natural history and clinical consequences. N Engl J Med 350: 1118–1129

    Google Scholar 

  5. Gerlach JT, Diepolder HM, Zachoval R et al. (2003) Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125: 80–88

    Google Scholar 

  6. Jaeckel EM, Cornberg M, Wedemeyer H et al. (2001) Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345: 1452–1457

    Google Scholar 

  7. Janssen HL, van Zonneveld M, Senturk H et al. (2005) Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365: 123–129

    Google Scholar 

  8. Mangia A, Santoro R, Minerva N et al. (2005) Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3. N Engl J Med 352: 2609–2617

    Google Scholar 

  9. Marcellin P, Lau GK, Bonino F et al. (2004) Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med 351: 1206–1217

    Google Scholar 

  10. Moradpour D, Blum HE (2004) Hepatitis C. Ther Umsch 61: 493–498

    Google Scholar 

  11. Poynard T, Yuen MF, Ratziu V, Lai CL (2003) Viral hepatitis C. Lancet 362: 2095–2100

    Google Scholar 

  12. Santantonio T, Fasano M, Sinisi E et al. (2005) Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. J Hepatol 42: 329–333

    Google Scholar 

  13. Siegl G (2004) Hepatitis A and E enterically transmitted virus infections of the liver. Ther Umsch 61: 481–486

    Google Scholar 

  14. Taylor JM (2006) Hepatitis delta virus. Virology 344: 71–76

    Google Scholar 

  15. Van Bommel F, Wunsche T, Mauss A et al. (2004) Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology 40: 1421–1425

    Google Scholar 

  16. Wagner von M, Huber M, Berg T et al. (2005) Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C. Gastroenterology 129: 522–527

    Google Scholar 

  17. Weizsäcker von F (2005) Management of chronic hepatitis B. Schweiz Rundsch Med Prax 94: 649–652

    Google Scholar 

  18. Wiegand J, Buggisch P, Boecher W et al. (2006) Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology 43: 250–256

    Google Scholar 

  19. Zeuzem S, Buti M, Ferenci P et al. (2006) Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. J Hepatol 44: 97–103

    Google Scholar 

Download references

Interessenkonflikt:

Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

  1. Medizinische Universitätsklinik, Freiburg

    C. Neumann-Haefelin, H. C. Spangenberg & H. E. Blum

  2. Abteilung Innere Medizin II, Medizinische Universitätsklinik, Hugstetter Straße 55, 79106, Freiburg

    R. Thimme

Authors
  1. R. Thimme
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Neumann-Haefelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. C. Spangenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. E. Blum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Thimme.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thimme, R., Neumann-Haefelin, C., Spangenberg, H.C. et al. Virushepatitis A–E. Gastroenterologe 1, 61–74 (2006). https://doi.org/10.1007/s11377-006-0004-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11377-006-0004-2

Schlüsselwörter

Keywords

Search

Navigation